Edesa Biotech, Inc. · NASDAQ:EDSA
Velan Capital Investment Management LP reported a 9.99% stake in Edesa Biotech, Inc. (Schedule 13D)
Event Feb 12, 2025 · Filed Feb 18, 2025
Velan Capital Investment Management LP reported a 9.99% stake in Edesa Biotech, Inc., 693,551 shares, with active intent on Feb 12, 2025. Filed Feb 18, 2025 (Schedule 13D).
- Stake
- 9.99%
- Shares
- 693,551
- Intent
- Active
- What changed
- Crossed above 5%
- Filed together
- 9 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Velan Capital Master Fund LP | 6.20% | 427,926 |
| Velan Horizon Fund LP | 0.20% | 15,625 |
| Velan Capital Opportunity Fund II LLC | 3.60% | 250,000 |
| Velan Horizon GP LLC | 0.20% | 15,625 |
| Velan Capital Holdings LLC | 9.80% | 677,926 |
| Velan Capital Investment Management LP | 9.99% | 693,551 |
| Velan Capital Management LLC | 9.99% | 693,551 |
| Morgan Adam | 9.99% | 693,551 |
| VENKATARAMAN BALAJI | 9.99% | 693,551 |
Source
Related
- Edesa Biotech, Inc.
- Velan Capital Investment Management LP
- Edesa Biotech, Inc. shareholders
- Schedule 13D/A · Velan Capital Investment Management LP · Aug 25, 2026
- Schedule 13D/A · Velan Capital Investment Management LP · Mar 2, 2026
- Form 4 · Nijhawan Pardeep · Oct 6, 2026
- Form 4 · Nijhawan Pardeep · Sep 1, 2026
- Schedule 13G · Stonepine Capital Management, LLC · Aug 26, 2026
- Schedule 13D/A · Nijhawan Pardeep · Aug 25, 2026
- Form 4 · Nijhawan Pardeep · Aug 4, 2026